Spanish Red Biotech Pipeline

Novo Nordisk Pharma

IDegAsp (combination insulin degludec + insulin aspart)

Type: Biodrugs/ Drugs
Therapeutic area: Metabolic / Endocrinology
Indication: Diabetes type 2 and type 1
Phase: 4Registration, 3Phase III in Spain, 2Phase II, 1Phase I